North America's Dominance: Why the Region Leads the Global Biologics Market
The Global Biologic Therapy Market is characterized by a distinct regional imbalance, with North America (primarily the United States) maintaining a commanding lead, accounting for a market value of $130.0 billion in 2024. This dominance is not accidental; it is a direct result of several critical structural advantages. The region benefits from the world's highest healthcare expenditure per...
0 Comments 0 Shares 421 Views 0 Reviews
MTSocial https://mtsocial.ir